Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Makker

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2022
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomasDara S Ross, Kelly A Devereaux, Cao Jin, et al.
Gynecologic Oncology|August 2, 2012
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancerAna P Kiess, Shari Damast, Vicky Makker, et al.
The Oncologist|July 31, 2023
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus PembrolizumabNicoletta Colombo, Domenica Lorusso, Bradley J Monk, et al.
Annals of Surgical Oncology|March 5, 2017
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Chiara Scelzo, Celeste Straight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Annals of Surgical Oncology|May 22, 2015
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Oliver Zivanovic, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2013
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complicationsSamith Sandadi, Edward J Tanner, Fady Khoury-Collado, et al.
Gynecologic Oncology|December 28, 2018
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyUrsula A Matulonis, Michael W Sill, Vicky Makker, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 26, 2021
Safety and Efficacy of Arterially Directed Liver Therapies in the Treatment of Hepatic Metastatic Ovarian Cancer: A Retrospective Single-Institution StudyEduardo A Lacayo, Sara Velayati, Ahmed Elsakka, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2022
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomasDara S Ross, Kelly A Devereaux, Cao Jin, et al.
Gynecologic Oncology|August 2, 2012
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancerAna P Kiess, Shari Damast, Vicky Makker, et al.
The Oncologist|July 31, 2023
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus PembrolizumabNicoletta Colombo, Domenica Lorusso, Bradley J Monk, et al.
Annals of Surgical Oncology|March 5, 2017
Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Chiara Scelzo, Celeste Straight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Annals of Surgical Oncology|May 22, 2015
Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node MappingMaria B Schiavone, Oliver Zivanovic, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2013
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complicationsSamith Sandadi, Edward J Tanner, Fady Khoury-Collado, et al.
Gynecologic Oncology|December 28, 2018
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyUrsula A Matulonis, Michael W Sill, Vicky Makker, et al.
Gynecologic Oncology|October 9, 2013
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasionChristine H Kim, Fady Khoury-Collado, Emma L Barber, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 26, 2021
Safety and Efficacy of Arterially Directed Liver Therapies in the Treatment of Hepatic Metastatic Ovarian Cancer: A Retrospective Single-Institution StudyEduardo A Lacayo, Sara Velayati, Ahmed Elsakka, et al.
Pageof 14